CME credits: 0.25

Valid until: 15-09-2020

Claim your CME credit at https://reachmd.com/national-eye-institute/nei-blindness-prevention-initiative/viewpoints-on-cases-in-diabetic-retinopathy-what-the-optometrist-needs-to-know/10904/

A paradigm shift is occurring for the management of nonproliferative diabetic retinopathy, with new evidence demonstrating that patients with moderately-severe to severe nonproliferative diabetic retinopathy can benefit from anti-VEGF treatment. Join Dr. Mark Dunbar and Dr. Jay Haynie as they discuss the evidence for this evolution and what optometrists need to know to protect the vision of their patients with diabetic eye disease.

Vision loss caused by diabetic retinopathy can have a significant impact on a patient's quality of life. This activity emphasizes more assertive action in clinical practice for patient with diabetes. The acronym ASSERT-D is a reminder to Assess and Screen for Eye health and Refer or Treat patients with Diabetes.